非大腸癌的血清癌胚胎抗原的研究

CEA Study in Non-Colonic Cancer

薛如璋(Lu-Chung Shieu) ； 蔡道桂(Daw-Guey Tsay) ； 程東照(T.C. Cheng) ； 章淑貞(S.C. Cheng)

《中華放射線醫學雜誌》 9卷4期 (1984/12) Pp. 337-342

摘要

271例非大腸腺癌的惡性腫瘤中，血清癌胚胎抗原測大於3.5ng/ml 的，有104例佔38.38%。其中之消化道腫瘤有118例，63例血清癌胚胎抗原測值，呈異常升高佔53.39%; 116例女性生殖器官腫瘤中，血清胚胎抗原測值超過3.5ng/ml的，有28例佔24.14%: 37例其他部位腫瘤患者中，有35.14%（13例）血清癌胚胎抗原測值，大於3.5ng/ml。
總之，血清癌胚胎抗原測值，在許多非大腸腺癌的惡性腫瘤中，亦有升高的現象，在惡性腫瘤的早期診斷上，無法做為常規的篩檢工具，在惡性腫瘤的鑑別診斷上，亦少有價值。

並列摘要

In the study of 271 cases of non-colonic cancer, serum CEA levels have been detected. The assay shows abnormality in 63 of 118 cases (53.4%) of G-I tract cancer, 28 of 116 cases (24.14%) of Gyn. cancer and 13 of 37 cases (35.1%) in other organ’s neogrowths.
Raised serum levels of CEA occur in many non-colonic cancers. The present method of estimating CEA may be not helpful, which is applied as preliminary screening tests for the detection of cancer and differential diagnosis of neoplastic disorders.